Christoph Klade
AOP Orphan (Austria)(AT)Hewlett-Packard (Austria)(AT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Hepatitis C virus research, Cytokine Signaling Pathways and Interactions, Mosquito-borne diseases and control
Most-Cited Works
- → Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study(2020)334 cited
- → Identification of tumor antigens in renal cell carcinoma by serological proteome analysis(2001)204 cited
- → Ropeginterferon alfa-2b, a novel IFNα-2b, induces high response rates with low toxicity in patients with polycythemia vera(2015)178 cited
- → Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis(2002)165 cited
- → Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41(2008)153 cited
- → Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects(2006)